« Back to Record
Citation APA

Van Antwerpen, P., Zouaoui Boudjeltia, K., Dufrasne, F., Legssyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2006). Flufenamic acid and its 5-hydroxy metabolite inhibit the specific oxidation of LDL by the Myeloperoxidase / H2O2 / Cl- system. Poster session presented at XIV International Symposium on Atherosclerosis (18-22 June 2006: Roma, Italy).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/68882

Van Antwerpen, P., Zouaoui Boudjeltia, K., Dufrasne, F., Legssyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2006). Flufenamic acid and its 5-hydroxy metabolite inhibit the specific oxidation of LDL by the Myeloperoxidase / H2O2 / Cl- system. Poster session presented at XIV International Symposium on Atherosclerosis (18-22 June 2006: Roma, Italy).